We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03656536
Brief Title: A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma (FIGHT-302)

First Submitted : August 29, 2018
First Submitted that Met QC Criteria : August 30, 2018
First Posted : September 4, 2018

Last Update Submitted that Met QC Criteria : November 15, 2022
Last Update Posted : November 17, 2022